Provention Bio’s Crohn’s Disease Trial is Fully Enrolled, with Top-line Results Expected Later in Year
News
Provention Bio has completed patient enrollment for a Phase 2a clinical trial evaluating the efficacy and safety of its investigational oral therapy — PRV-6527 — for moderate to severe Crohn’s ... Read more